Analyst Recommendations

JMP Securities analyst issues MARKET PERFORM recommendation for LPLA on January 4, 2024 03:00PM ET. The previous analyst recommendation was Market Perform.LPLA was trading at $232.805 at issue...

January 4, 2024   LPLA 0.08%

Barclays analyst issues OVERWEIGHT recommendation for DG on January 4, 2024 02:10PM ET. The previous analyst recommendation was Equal-Weight.DG was trading at $134.41 at issue of the analyst...

January 4, 2024   DG -0.71%

Needham analyst issues BUY recommendation for EFX on January 4, 2024 02:36PM ET. The previous analyst recommendation was Buy.EFX was trading at $235.7175 at issue of the analyst...

January 4, 2024   EFX 0.91%

Truist Financial analyst issues BUY recommendation for IQV on January 4, 2024 02:00PM ET. The previous analyst recommendation was Buy.IQV was trading at $220.06 at issue of the...

January 4, 2024   IQV 0.08%

Raymond James analyst issues MARKET PERFORM recommendation for BC on January 4, 2024 02:00PM ET. The previous analyst recommendation was Outperform.BC was trading at $89.1 at issue of...

January 4, 2024   BC -0.16%

Guggenheim analyst issues UNDERPERFORM recommendation for ROE on January 4, 2024 02:00PM ET. The previous analyst recommendation was Underperform.ROE was trading at $0 at issue of the analyst...

January 4, 2024   ROE -0.32%

Raymond James analyst issues UNDERPERFORM recommendation for RJF on January 4, 2024 02:00PM ET. The previous analyst recommendation was Underperform.RJF was trading at $111.01 at issue of the...

January 4, 2024   RJF 0.41%

Wells Fargo analyst issues MARKET PERFORM recommendation for ROP on January 4, 2024 02:01PM ET. The previous analyst recommendation was Market Perform.ROP was trading at $525.48 at issue...

January 4, 2024   ROP 1.12%

Raymond James analyst issues STRONG BUY recommendation for SHAK on January 4, 2024 02:07PM ET. The previous analyst recommendation was Strong Buy.SHAK was trading at $69.72 at issue...

January 4, 2024   SHAK 3.49%

Mizuho Securities analyst issues BUY recommendation for EMR on January 4, 2024 05:49AM ET. The previous analyst recommendation was Neutral.EMR was trading at $95.71 at issue of the...

January 4, 2024   EMR -0.26%